Certolizumab pegol treatment for leg ulcers due to rheumatoid vasculitis

Maureen Tania Meling; Akane Minagawa; Tomomi Miyake; Atsuko Ashida; Ryuhei Okuyama

doi:10.1016/j.jdcr.2021.10.004

Certolizumab pegol treatment for leg ulcers due to rheumatoid vasculitis

JAAD Case Rep. 2021 Oct 13:18:12-14. doi: 10.1016/j.jdcr.2021.10.004. eCollection 2021 Dec.

Authors

Maureen Tania Meling¹, Akane Minagawa¹, Tomomi Miyake¹, Atsuko Ashida¹, Ryuhei Okuyama¹

Affiliation

¹ Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan.

No abstract available

Keywords: CZP, certolizumab pegol; MTX, methotrexate; PSL, prednisolone; RA, rheumatoid arthritis; RV, rheumatoid vasculitis; TNF-α inhibitor; TNF-α, tumor necrosis factor-alfa; autoimmune disease; biological therapy; certolizumab pegol; leg ulcer; rheumatoid arthritis; rheumatoid vasculitis; skin ulcer.

Publication types

Case Reports